COLL Earnings Collegium Pharmaceutical, Inc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.40 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 1.73 | 2026-02-26 | 10-K |
| FY 2025 | 2025-09-30 | 0.84 | 2026-02-26 | 10-K |
| FY 2025 | 2025-06-30 | 0.34 | 2026-02-26 | 10-K |
| Q1 2026 | 2025-03-31 | 0.07 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 1.86 | 2026-02-26 | 10-K |
| FY 2025 | 2024-09-30 | 0.27 | 2026-02-26 | 10-K |
| FY 2025 | 2024-06-30 | 0.52 | 2026-02-26 | 10-K |
| FY 2025 | 2024-03-31 | 0.71 | 2026-02-26 | 10-K |
| FY 2025 | 2023-12-31 | 1.29 | 2026-02-26 | 10-K |
| FY 2024 | 2023-09-30 | 0.53 | 2025-02-27 | 10-K |
| FY 2024 | 2023-06-30 | 0.34 | 2025-02-27 | 10-K |
| FY 2024 | 2023-03-31 | -0.51 | 2025-02-27 | 10-K |
| FY 2024 | 2022-12-31 | -0.74 | 2025-02-27 | 10-K |
| FY 2023 | 2022-09-30 | 0.01 | 2024-02-22 | 10-K |
| FY 2023 | 2022-06-30 | -0.15 | 2024-02-22 | 10-K |
| FY 2023 | 2022-03-31 | -0.39 | 2024-02-22 | 10-K |
| FY 2023 | 2021-12-31 | 1.86 | 2024-02-22 | 10-K |
| FY 2022 | 2021-09-30 | 0.22 | 2023-02-23 | 10-K |
| FY 2022 | 2021-06-30 | 1.79 | 2023-02-23 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.